Home > Publications database > Sex differences in pancreatic cancer.[Geschlechtsunterschiede beim Pankreaskarzinom.] > print |
001 | 292327 | ||
005 | 20250417095542.0 | ||
024 | 7 | _ | |a 10.1007/s00104-024-02150-6 |2 doi |
024 | 7 | _ | |a pmid:39145868 |2 pmid |
024 | 7 | _ | |a 2731-6971 |2 ISSN |
024 | 7 | _ | |a 2731-698X |2 ISSN |
024 | 7 | _ | |a altmetric:166533321 |2 altmetric |
037 | _ | _ | |a DKFZ-2024-01678 |
041 | _ | _ | |a German |
082 | _ | _ | |a 610 |
100 | 1 | _ | |a Holze, Magdalena |b 0 |
245 | _ | _ | |a Sex differences in pancreatic cancer.[Geschlechtsunterschiede beim Pankreaskarzinom.] |
260 | _ | _ | |a [Berlin] |c 2024 |b Springer Medizin Verlag GmbH |
336 | 7 | _ | |a article |2 DRIVER |
336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1724074249_15512 |2 PUB:(DE-HGF) |x Review Article |
336 | 7 | _ | |a ARTICLE |2 BibTeX |
336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
520 | _ | _ | |a This review article discusses the currently available evidence on the importance of biological and social sex in pancreatic cancer in the context of the operative, perioperative and multimodal treatment. In pancreatic cancer there are gender differences with respect to the incidence, treatment response and prognosis. Sex significantly influences both innate and adaptive immune responses, thereby affecting treatment response and survival rates. Women are less likely to receive systemic treatment and tend to wait longer for surgery but have better perioperative outcomes after pancreatic resection. Overall, female pancreatic cancer patients seem to have longer survival under treatment; however, they report a subjectively lower quality of life and higher disease burden. |
536 | _ | _ | |a 314 - Immunologie und Krebs (POF4-314) |0 G:(DE-HGF)POF4-314 |c POF4-314 |f POF IV |x 0 |
588 | _ | _ | |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de |
650 | _ | 7 | |a Gender medicine |2 Other |
650 | _ | 7 | |a Immune response |2 Other |
650 | _ | 7 | |a Pancreatic surgery |2 Other |
650 | _ | 7 | |a Precision medicine |2 Other |
650 | _ | 7 | |a Treatment response |2 Other |
700 | 1 | _ | |a Ahmed, Azaz |0 P:(DE-He78)bac8c2c56238485ecf0475ff14438430 |b 1 |u dkfz |
700 | 1 | _ | |a Loos, Martin |b 2 |
700 | 1 | _ | |a Michalski, Christoph W |b 3 |
700 | 1 | _ | |a Klotz, Rosa |b 4 |
773 | _ | _ | |a 10.1007/s00104-024-02150-6 |g Vol. 95, no. 9, p. 709 - 714 |0 PERI:(DE-600)3120893-9 |n 9 |p 709 - 714 |t Die Chirurgie |v 95 |y 2024 |x 2731-6971 |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/292327/files/s00104-024-02150-6.pdf |
856 | 4 | _ | |u https://inrepo02.dkfz.de/record/292327/files/s00104-024-02150-6.pdf?subformat=pdfa |x pdfa |
909 | C | O | |o oai:inrepo02.dkfz.de:292327 |p VDB |
910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-He78)bac8c2c56238485ecf0475ff14438430 |
913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF4-310 |0 G:(DE-HGF)POF4-314 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-300 |4 G:(DE-HGF)POF |v Immunologie und Krebs |x 0 |
914 | 1 | _ | |y 2024 |
915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2023-08-25 |w ger |
915 | _ | _ | |a DEAL Springer |0 StatID:(DE-HGF)3002 |2 StatID |d 2023-08-25 |w ger |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2023-08-25 |
915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2023-08-25 |
915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CHIRURGIE : 2022 |d 2023-08-25 |
915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2023-08-25 |
915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2023-08-25 |
915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |d 2023-08-25 |
920 | 1 | _ | |0 I:(DE-He78)D196-20160331 |k D196 |l Translationale Immuntherapie |x 0 |
980 | _ | _ | |a journal |
980 | _ | _ | |a VDB |
980 | _ | _ | |a I:(DE-He78)D196-20160331 |
980 | _ | _ | |a UNRESTRICTED |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|